Learn how to buy shares of Valeo Pharma (vph.cn) | step by step in english

Valeo Pharma

Valeo Pharma Inc., a specialty pharmaceutical company, is engaged in the acquisition, licensing and marketing of pharmaceutical products with a primary focus on neurodegenerative diseases, oncology and supportive care and hospital products. Its product portfolio includes Redesca, a low molecular weight heparin (LMWH) biosimilar to treat and prevent deep vein thrombosis and pulmonary embolism; Hesperco, a capsule that supports the immune system; Onstryv, an oral medication for Parkinson’s disease; M-Eslon, a narcotic analgesic for pain management; and Ametop Gel, a tetracaine hydrochloride gel for percutaneous anesthetic to produce anesthesia of the skin prior to venipuncture or venous cannulation. The company also provides sodium ethacrynate, a loop diuretic used to treat high blood pressure and swelling caused by disease. such as congestive heart failure, liver failure, and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Additionally, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain control and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. liver failure and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Additionally, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as several hospital products for antifungals, antibiotics, pain control, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. liver failure and kidney failure; Synacthen Depot, a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Besides, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Besides, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. a synthetic adrenocorticotropic hormone to treat multiple sclerosis and nephrotic syndrome; Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Besides, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain control and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. Ondansetron for the prevention of nausea and vomiting caused by cancer chemotherapy; Benztropine, an anticholinergic agent used to treat Parkinson’s disease; and Yondelis, a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Additionally, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. Additionally, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain management, and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada. a new marine-derived antitumor agent for the treatment of patients with metastatic liposarcoma or leiomyosarcoma after failure of prior anthracycline and ifosfamide chemotherapy. In addition, its product portfolio includes piperacillin/tazobactam, an injectable antibiotic, as well as various hospital products for antifungals, antibiotics, pain control and other indications. The company was incorporated in 2003 and is headquartered in Kirkland, Canada.

Learn how to buy shares of Valeo Pharma (vph.cn) | step by step in spanish

Would you like to buy Valeo Pharma (vph.cn) shares in Canada from Spain and using a regulated broker? Are you interested in being able to invest your monthly earnings and make a profit in the stock market? With this guide I am going to show you how easy it is to create a debit account , a reliable German investment bank and very low commissions, and how you can get your first shares of the company Valeo Pharma Inc. (VPH.CN) (vph.cn) quickly and easily.

The tutorial is simple :

  • First of all, we are going to register in DeGiro, an interface in which we will invest in shares of the company Valeo Pharma Inc. (VPH.CN), (vph.cn).
  • In 2nd place we will add capital and thus be able to make the 1st investment in Degiro.
  • When we see the funds we will proceed to locate Valeo Pharma looking for its TICKER, which is vph.cn.
  • To finish we only have to indicate the number of shares that we want to buy, value and type of order.

Perhaps the step by step has been a bit basic for you, therefore I am going to summarize the step by step with images.

Registration Tutorial for Degiro

First of all we must register in degiro from this link :

buy shares of Valeo Pharma Inc. (VPH.CN)

It will require an email, a username and a password to enter, and then we will continue using the link that they have sent us by mail.

Soon degiro will require some essential data in order to corroborate our identity . We need to have on hand the passport, ID or driving document, your mobile number and the bank account number that we are going to use to carry out our first deposit. If you do not perceive what method this format is, you can review this simple guide article that we wrote at Educacep .

Stock Valeo Pharma

Once our account is verified, we can put money from the Deposit/Withdraw tab. We will be able to carry out a transaction that will take more or less two to three days, or make the deposit instantly using Sofort, a truly secure and 100% reliable payment gateway.

transfer money bank Valeo Pharma

How to buy Valeo Pharma (vph.cn) shares through DeGiro

As soon as we have the capital we have the possibility of investing in our 1st action. You can go to the place order button that is located in the upper right corner or use the Degiro search engine and paste the ticker. In the following screenshot you will see that I have put the Amazon ticker but in your case you have to put (vph.cn), the Valeo Pharma ticker. As we are talking about an action, we will see that the related businesses and companies are listed and there we will see to find Valeo Pharma. The most important thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Valeo Pharma Inc. (VPH.CN) is listed in Canada. This step is essential so do not get confused.

american bag closing valeo pharma

At the time of placing the order we will pay special attention to what I am going to explain to you . We can proceed to place a limit or market order. Imagine that you want to buy a Valeo Pharma share, but its true price is higher. With the limit order we will introduce the value at which we want to make the purchase and until there are no shares for sale at that price, the acquisition of the share will not be executed. With a market order, DeGiro will buy the number of shares that we have adjusted to the current selling price, which will be very close to today’s trading price.

best price limit order Valeo Pharma Inc. (VPH.CN)

In both cases it is essential that you look at the type of position: permanent or day . For example, in Spain, the stock market is listed in the morning until 1 in the afternoon, and in the USA it coincides with the afternoon schedule in Spain. If the order is fixed, it will continue until it is executed, but if you choose the «of the day» option, at the time the stock market session ends, if it has not been carried out, it will be deleted from your tab in Activity – Orders in Pending status.

Hopefully this detailed article has helped you to buy shares in Valeo Pharma. Until next time.

  Company information
  • Valeo Pharma Inc. (VPH.CN) Address: 16667 Hymus Boulevard Kirkland, QC H9H 4R9 Canada 514694 0150 – Website: http://www.valeopharma.com
  • Ticker: hpv.cn
  • Sector: Health
  • Industry: Employees
  • Number of employees: 38
  • Listed market: Canada

key executives

Name Title Salary exercised Year of birth
Mr Steven Saviuk CEO and Vice President 184.46k N/A 1959
Mr Luc Mainville MBA, MBA Senior Vice President and Chief Financial Officer 247.72k N/A 1964
Mr. Marc Leger Senior Vice President and Chief Commercial Officer 152.24k N/A N/A
Mr. Frederic Dumais Director of Communications and Investor Relations N/A N/A N/A
Mr. Frederic Fasano Pres, COO and Director N/A N/A 1968
Mr Guy Paul Allard Vice President of Legal Affairs and Sec. Corp. N/A N/A N/A

Recent events of :

We have no recent events for this company.